ELYTE Trademark

Trademark Overview


On Wednesday, August 19, 1998, a trademark application was filed for ELYTE with the United States Patent and Trademark Office. The USPTO has given the ELYTE trademark a serial number of 75539532. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Thursday, April 6, 2000. The ELYTE trademark is filed in the Pharmaceutical Products category with the following description:

ERYTHROMYCIN TOPICAL GEL

General Information


Serial Number75539532
Word MarkELYTE
Filing DateWednesday, August 19, 1998
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateThursday, April 6, 2000
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 13, 1999

Trademark Statements


Goods and ServicesERYTHROMYCIN TOPICAL GEL

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 28, 1998
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressANAHEIM, CA 92808

Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressANAHEIM, CA 92808

Trademark Events


Event DateEvent Description
Tuesday, July 4, 2000ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 5, 1999NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 13, 1999PUBLISHED FOR OPPOSITION
Friday, June 11, 1999NOTICE OF PUBLICATION
Friday, April 9, 1999APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 6, 1999ASSIGNED TO EXAMINER

Related Keywords


elyte topical erythromycin